Adozelesin

Adozelesin
Identifiers
110314-48-2 YesY
3D model (Jmol) Interactive image
ChEMBL ChEMBL35493
ChemSpider 317091
PubChem 357194
UNII 6N3M4XJR2V YesY
Properties
C30H22N4O4
Molar mass 502.53 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Adozelesin is an experimental antitumor drug of the duocarmycin class.[1] It binds to and alkylates DNA, resulting in a reduction of both cellular and simian virus 40 (SV40) DNA replication which ultimately reduces the rate of cancer growth.[2]

References

  1. Wang, Y; Beerman, TA; Kowalski, D (2001). "Antitumor drug adozelesin differentially affects active and silent origins of DNA replication in yeast checkpoint kinase mutants". Cancer Research. 61 (9): 3787–94. PMID 11325853.
  2. Liu, J.-S.; Kuo, S.-R.; McHugh, M. M.; Beerman, T. A.; Melendy, T. (14 January 2000). "Adozelesin Triggers DNA Damage Response Pathways and Arrests SV40 DNA Replication through Replication Protein A Inactivation". Journal of Biological Chemistry. 275 (2): 1391–1397. doi:10.1074/jbc.275.2.1391.
This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.